Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Gonadotropin-Releasing Hormone (GnRH) Agonist Global Market Report 2025
Download Free Sample Buy Now
Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Gonadotropin-Releasing Hormone (GnRH) Agonist Global Market Report 2025

By Type (Leuprorelin, Goserelin, Taltirelin, Histrelin, Other Types), By Formulation (Injectable, Implants, Oral, Nasal Sprays), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Prostate Cancer, Breast Cancer, Endometriosis, Uterine Fibroids, Precocious Puberty, Fertility Treatment, Other Applications), By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

• Gonadotropin-Releasing Hormone (GnRH) Agonist market size has reached to $4.1 billion in 2024

• Expected to grow to $4.61 billion in 2029 at a compound annual growth rate (CAGR) of 2.5%

• Growth Driver: Rising Prevalence Of Hormone-Related Diseases Drives Growth In The Gonadotropin-Releasing Hormone (GnRH) Agonist Market

• Market Trend: Advancements In Oral Androgen Deprivation Therapy For Advanced Prostate Cancer

• North America was the largest region in 2024.

What Is Covered Under Gonadotropin-Releasing Hormone (GnRH) Agonist Market?

Gonadotropin-releasing hormone (GnRH) agonists are synthetic agents that replicate the action of natural GnRH, which triggers the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These agonists are used to manage hormonal imbalances by controlling hormone levels. They are particularly useful in fertility treatments to regulate and prevent premature ovulation during procedures like in vitro fertilization.

The main types of gonadotropin-releasing hormone (GnRH) agonists are leuprorelin, goserelin, taltirelin, histrelin, and others. Leuprorelin is a synthetic hormone used to manage prostate cancer, endometriosis, and uterine fibroids by reducing hormone production and is administered via monthly or quarterly injections. It is formulated in different ways, such as injectables, implants, oral, and nasal sprays, and sold through various distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies. It is used for several applications, such as prostate cancer, breast cancer, endometriosis, uterine fibroids, precocious puberty, fertility treatment, and others, and is used by various end-users, including hospitals, specialty clinics, ambulatory surgical centers (ASCs), and others.

Gonadotropin-Releasing Hormone (GnRH) Agonist Market Size and growth rate 2025 to 2029: Graph

What Is The Gonadotropin-Releasing Hormone (GnRH) Agonist Market Size 2025 And Growth Rate?

The gonadotropin-releasing hormone (GnRH) agonist market size has grown steadily in recent years. It will grow from $4.1 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 2.1%. The growth in the historic period can be attributed to rising awareness and diagnosis of hormonal disorders, increasing prevalence of hormone-related diseases, increasing prevalence of prostate cancer, growing awareness about hormone therapy, increase demand for long-term safety and efficacy.

What Is The Gonadotropin-Releasing Hormone (GnRH) Agonist Market Growth Forecast?

The gonadotropin-releasing hormone (GnRH) agonist market size is expected to see steady growth in the next few years. It will grow to $4.61 billion in 2029 at a compound annual growth rate (CAGR) of 2.5%. The growth in the forecast period can be attributed to rising awareness and early diagnosis, rising healthcare expenditure, increasing use in fertility treatments, rising demand for personalized medicine, and increasing research funding and grants. Major trends in the forecast period include advancements in drug delivery systems, advancements in oncology and reproductive medicine, growing demand for hormone therapy options, increasing research and development, and rise of long-acting formulations.

The forecast of 2.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to leuprolide acetate and goserelin implants imported from Switzerland and India, potentially compromising fertility treatments and prostate cancer care while increasing endocrinology medication costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Gonadotropin-Releasing Hormone (GnRH) Agonist Market Segmented?

1) By Type: Leuprorelin, Goserelin, Taltirelin, Histrelin, Other Types

2) By Formulation: Injectable, Implants, Oral, Nasal Sprays

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By Application: Prostate Cancer, Breast Cancer, Endometriosis, Uterine Fibroids, Precocious Puberty, Fertility Treatment, Other Applications

5) By End-User: Hospital, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Other End-Users

Subsegments:

1) By Leuprorelin: Injectable Leuprorelin, Implantable Leuprorelin

2) By Goserelin: Goserelin Injection, Goserelin Implant

3) By Taltirelin: Injectable Taltirelin, Oral Taltirelin

4) By Histrelin: Histrelin Implant, Histrelin Injection

5) By Other Type: Triptorelin, Buserelin, Nafarelin

What Is Driving The Gonadotropin-Releasing Hormone (GnRH) Agonist Market? Rising Prevalence Of Hormone-Related Diseases Drives Growth In The Gonadotropin-Releasing Hormone (GnRH) Agonist Market

The increasing prevalence of hormone-related diseases is expected to propel the growth of the gonadotropin-releasing hormone (GnRH) agonist market going forward. Hormone-related disorders are medical conditions caused by imbalances or dysfunctions in the endocrine system, which produces and regulates hormones. It includes diseases such as diabetes, hyperthyroidism, and prostate cancer. The rising incidence of hormone-related diseases are caused due to environmental factors, obesity and metabolic syndrome, genetics, and the aging population. Gonadotropin-releasing hormone (GnRH) agonists carefully manage hormone levels and offer a tailored approach to treating problems associated with hormonal imbalances and dependent diseases. For instance, In December 2023, the Australian Bureau of Statistics reported that in 2022, approximately one in twenty people, or 5.3% (around 1.3 million individuals), were living with diabetes. The prevalence of diabetes was similar among genders, with rates of 5.8% for males and 4.9% for females. Additionally, diabetes was the seventh leading cause of death in Australia, accounting for 6,050 fatalities in that year. Therefore, the increasing prevalence of hormone-related diseases is driving the growth of the gonadotropin-releasing hormone (GnRH) agonist industry.

Who Are The Major Players In The Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market?

Major companies operating in the gonadotropin-releasing hormone (GnRH) agonist market are Pfizer Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Sandoz Group AG, Ipsen Pharma, Aurobindo Pharma Limited, Cipla Limited, Dr Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Ferring Pharmaceuticals, Amneal Pharmaceuticals Inc., Endo International plc, Lupin Limited, Gland Pharma Limited, Glenmark Pharmaceuticals Ltd., Zydus Lifesciences Limited, Bachem Holding AG, Tolmar Pharmaceuticals Inc., Debiopharm Group, Sun Pharmaceutical Industries Ltd.

What Are The Key Trends Of The Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market? Advancements In Oral Androgen Deprivation Therapy For Advanced Prostate Cancer

Major companies operating in the gonadotropin-releasing hormone (GnRH) agonist market are developing advanced androgen deprivation therapy drugs to enhance the effectiveness and precision of treatment for hormone-sensitive cancers. androgen deprivation therapy (ADT) drugs, including gonadotropin-releasing hormone (GnRH) analogs, reduce or eliminate androgen levels to slow or halt hormone-sensitive cancer growth. For instance, in January 2024, Zydus Lifesciences Limited, an India-based pharmaceutical company, launched Relugolix under the brand name Rexigo. It is India's first and only once-daily oral therapy for testosterone suppression in advanced prostate cancer, eliminating the need for injectable treatments. This convenient oral option features Relugolix, a globally recognized active ingredient that delivers rapid testosterone suppression. Rexigo is 50% more affordable than existing injectable alternatives for advanced prostate cancer in India. Its introduction represents a major advancement in prostate cancer care, offering a safe, effective, and user-friendly treatment choice for both patients and healthcare providers.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gonadotropin-Releasing Hormone (GnRH) Agonist Market? Debiopharm And Aspen Holdings Partnered To Introduce Trelstar For Prostate Cancer Treatment In South Africa

In February 2022, Debiopharm, a Switzerland-based manufacturer of gonadotropin-releasing hormone (GnRH), agonists, partnered with Aspen Holdings. The partnership intends to introduce Trelstar in South Africa as a treatment for locally advanced and metastatic hormone-dependent prostate cancer. The collaboration aims to result in a world-class oncology product that will greatly contribute to prostate cancer treatment in the region, hence improving the overall treatment landscape for impacted patients. Aspen Holdings is a South Africa-based pharmaceutical company that offers specialty and generic pharmaceuticals.

What Is The Regional Outlook For The Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market?

North America was the largest region in the gonadotropin-releasing hormone (GnRH) agonist market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gonadotropin-Releasing Hormone (GnRH) Agonist Market?

The gonadotropin-releasing hormone (GnRH) agonists market consists of sales of triptorelin, buserelin, and nafarelin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gonadotropin-Releasing Hormone (GnRH) Agonist Industry?

The gonadotropin-releasing hormone (gnrh) agonist market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gonadotropin-releasing hormone (gnrh) agonist industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Gonadotropin-Releasing Hormone (GnRH) Agonist Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.19 billion
Revenue Forecast In 2034 $4.61 billion
Growth Rate CAGR of 2.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Leuprorelin, Goserelin, Taltirelin, Histrelin, Other Types
2) By Formulation: Injectable, Implants, Oral, Nasal Sprays
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Prostate Cancer, Breast Cancer, Endometriosis, Uterine Fibroids, Precocious Puberty, Fertility Treatment, Other Applications
5) By End-User: Hospital, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Other End-Users Subsegments: 1) By Leuprorelin: Injectable Leuprorelin, Implantable Leuprorelin
2) By Goserelin: Goserelin Injection, Goserelin Implant
3) By Taltirelin: Injectable Taltirelin, Oral Taltirelin
4) By Histrelin: Histrelin Implant, Histrelin Injection
5) By Other Type: Triptorelin, Buserelin, Nafarelin
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Sandoz Group AG, Ipsen Pharma, Aurobindo Pharma Limited, Cipla Limited, Dr Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Ferring Pharmaceuticals, Amneal Pharmaceuticals Inc., Endo International plc, Lupin Limited, Gland Pharma Limited, Glenmark Pharmaceuticals Ltd., Zydus Lifesciences Limited, Bachem Holding AG, Tolmar Pharmaceuticals Inc., Debiopharm Group, Sun Pharmaceutical Industries Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Gonadotropin-Releasing Hormone (GnRH) Agonist Market Characteristics

3. Gonadotropin-Releasing Hormone (GnRH) Agonist Market Trends And Strategies

4. Gonadotropin-Releasing Hormone (GnRH) Agonist Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Growth Analysis And Strategic Analysis Framework

5.1. Global Gonadotropin-Releasing Hormone (GnRH) Agonist PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market Growth Rate Analysis

5.4. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Total Addressable Market (TAM)

6. Gonadotropin-Releasing Hormone (GnRH) Agonist Market Segmentation

6.1. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Leuprorelin

Goserelin

Taltirelin

Histrelin

Other Types

6.2. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable

Implants

Oral

Nasal Sprays

6.3. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prostate Cancer

Breast Cancer

Endometriosis

Uterine Fibroids

Precocious Puberty

Fertility Treatment

Other Applications

6.5. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Specialty Clinics

Ambulatory Surgical Centers (ASCs)

Other End-Users

6.6. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Leuprorelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Leuprorelin

Implantable Leuprorelin

6.7. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Goserelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Goserelin Injection

Goserelin Implant

6.8. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Taltirelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Taltirelin

Oral Taltirelin

6.9. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Histrelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Histrelin Implant

Histrelin Injection

6.10. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Triptorelin

Buserelin

Nafarelin

7. Gonadotropin-Releasing Hormone (GnRH) Agonist Market Regional And Country Analysis

7.1. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gonadotropin-Releasing Hormone (GnRH) Agonist Market

8.1. Asia-Pacific Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gonadotropin-Releasing Hormone (GnRH) Agonist Market

9.1. China Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

9.2. China Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gonadotropin-Releasing Hormone (GnRH) Agonist Market

10.1. India Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gonadotropin-Releasing Hormone (GnRH) Agonist Market

11.1. Japan Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

11.2. Japan Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gonadotropin-Releasing Hormone (GnRH) Agonist Market

12.1. Australia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gonadotropin-Releasing Hormone (GnRH) Agonist Market

13.1. Indonesia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gonadotropin-Releasing Hormone (GnRH) Agonist Market

14.1. South Korea Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

14.2. South Korea Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market

15.1. Western Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

15.2. Western Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gonadotropin-Releasing Hormone (GnRH) Agonist Market

16.1. UK Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gonadotropin-Releasing Hormone (GnRH) Agonist Market

17.1. Germany Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gonadotropin-Releasing Hormone (GnRH) Agonist Market

18.1. France Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gonadotropin-Releasing Hormone (GnRH) Agonist Market

19.1. Italy Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gonadotropin-Releasing Hormone (GnRH) Agonist Market

20.1. Spain Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market

21.1. Eastern Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

21.2. Eastern Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gonadotropin-Releasing Hormone (GnRH) Agonist Market

22.1. Russia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gonadotropin-Releasing Hormone (GnRH) Agonist Market

23.1. North America Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

23.2. North America Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gonadotropin-Releasing Hormone (GnRH) Agonist Market

24.1. USA Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

24.2. USA Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gonadotropin-Releasing Hormone (GnRH) Agonist Market

25.1. Canada Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

25.2. Canada Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gonadotropin-Releasing Hormone (GnRH) Agonist Market

26.1. South America Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

26.2. South America Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gonadotropin-Releasing Hormone (GnRH) Agonist Market

27.1. Brazil Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gonadotropin-Releasing Hormone (GnRH) Agonist Market

28.1. Middle East Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

28.2. Middle East Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gonadotropin-Releasing Hormone (GnRH) Agonist Market

29.1. Africa Gonadotropin-Releasing Hormone (GnRH) Agonist Market Overview

29.2. Africa Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gonadotropin-Releasing Hormone (GnRH) Agonist Market Competitive Landscape And Company Profiles

30.1. Gonadotropin-Releasing Hormone (GnRH) Agonist Market Competitive Landscape

30.2. Gonadotropin-Releasing Hormone (GnRH) Agonist Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sandoz Group AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Gonadotropin-Releasing Hormone (GnRH) Agonist Market Other Major And Innovative Companies

31.1. Aurobindo Pharma Limited

31.2. Cipla Limited

31.3. Dr Reddy's Laboratories Ltd.

31.4. Intas Pharmaceuticals Ltd.

31.5. Ferring Pharmaceuticals

31.6. Amneal Pharmaceuticals Inc.

31.7. Endo International plc

31.8. Lupin Limited

31.9. Gland Pharma Limited

31.10. Glenmark Pharmaceuticals Ltd.

31.11. Zydus Lifesciences Limited

31.12. Bachem Holding AG

31.13. Tolmar Pharmaceuticals Inc.

31.14. Debiopharm Group

31.15. Sun Pharmaceutical Industries Ltd.

32. Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gonadotropin-Releasing Hormone (GnRH) Agonist Market

34. Recent Developments In The Gonadotropin-Releasing Hormone (GnRH) Agonist Market

35. Gonadotropin-Releasing Hormone (GnRH) Agonist Market High Potential Countries, Segments and Strategies

35.1 Gonadotropin-Releasing Hormone (GnRH) Agonist Market In 2029 - Countries Offering Most New Opportunities

35.2 Gonadotropin-Releasing Hormone (GnRH) Agonist Market In 2029 - Segments Offering Most New Opportunities

35.3 Gonadotropin-Releasing Hormone (GnRH) Agonist Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Leuprorelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Goserelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Taltirelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Histrelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Pfizer Inc. Financial Performance
  • Table 82: AbbVie Inc. Financial Performance
  • Table 83: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 84: Sandoz Group AG Financial Performance
  • Table 85: Ipsen Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Leuprorelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Goserelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Taltirelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Histrelin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Gonadotropin-Releasing Hormone (GnRH) Agonist Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Pfizer Inc. Financial Performance
  • Figure 82: AbbVie Inc. Financial Performance
  • Figure 83: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 84: Sandoz Group AG Financial Performance
  • Figure 85: Ipsen Pharma Financial Performance

Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Read More About Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Gonadotropin-Releasing Hormone (GnRH) Agonist Global Market Report 2025 – By Type (Leuprorelin, Goserelin, Taltirelin, Histrelin, Other Types), By Formulation (Injectable, Implants, Oral, Nasal Sprays), By Distribution C...

View Report

Hormone Therapy Global Market Report 2025 – By Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), By Route of Administration (Oral, Parenteral, Othe...

View Report

Human Chorionic Gonadotropin Global Market Report 2025 – By Technology (Natural Source Extraction, Recombinant Technology), By Therapeutic Area (Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Ot...

View Report

Follicle Stimulating Hormone Global Market Report 2025 – By Type (Recombinant FSH, Urinary FSH), By Application (Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications), By End-Users (Infertili...

View Report

Gynecology Drugs Global Market Report 2025 – By Therapeutics (Hormonal Therapy, Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, Other Indications),...

View Report

Human Growth Hormone Global Market Report 2025 – By Product (Liquid, Powder), By Brand (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Others Brands), By Route Of Administration (Oral, Intravenous, Intr...

View Report

Drugs For Hormonal Replacement Therapy Global Market Report 2025 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Ther...

View Report

GLP-1 Receptor Agonist Global Market Report 2025 – By Drug Class (Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs ), By Route Of Administration (Parenteral, Oral ), By End Users (Hospitals, Surgical Clinic...

View Report

Frequently Asked Questions

Gonadotropin-releasing hormone (GnRH) agonists are synthetic agents that replicate the action of natural GnRH, which triggers the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These agonists are used to manage hormonal imbalances by controlling hormone levels. They are particularly useful in fertility treatments to regulate and prevent premature ovulation during procedures like in vitro fertilization. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Hormone-Related Diseases Drives Growth In The Gonadotropin-Releasing Hormone (GnRH) Agonist Market. For further insights on this market, request a sample here

The gonadotropin-releasing hormone (gnrh) agonist market size has grown steadily in recent years. It will grow from $4.1 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 2.1%. The growth in the historic period can be attributed to rising awareness and diagnosis of hormonal disorders, increasing prevalence of hormone-related diseases, increasing prevalence of prostate cancer, growing awareness about hormone therapy, increase demand for long-term safety and efficacy. The gonadotropin-releasing hormone (gnrh) agonist market size is expected to see steady growth in the next few years. It will grow to " $4.61 billion in 2029 at a compound annual growth rate (CAGR) of 2.5%. The growth in the forecast period can be attributed to rising awareness and early diagnosis, rising healthcare expenditure, increasing use in fertility treatments, rising demand for personalized medicine, and increasing research funding and grants. Major trends in the forecast period include advancements in drug delivery systems, advancements in oncology and reproductive medicine, growing demand for hormone therapy options, increasing research and development, and rise of long-acting formulations. For further insights on this market, request a sample here

The gonadotropin-releasing hormone (gnrh) agonistmarket covered in this report is segmented –
1) By Type: Leuprorelin; Goserelin; Taltirelin; Histrelin; Other Types
2) By Formulation: Injectable; Implants; Oral; Nasal Sprays
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By Application: Prostate Cancer; Breast Cancer; Endometriosis; Uterine Fibroids; Precocious Puberty; Fertility Treatment; Other Applications
5) By End-User: Hospital; Specialty Clinics; Ambulatory Surgical Centers (ASCs); Other End-Users Subsegments:
1) By Leuprorelin: Injectable Leuprorelin; Implantable Leuprorelin
2) By Goserelin: Goserelin Injection; Goserelin Implant
3) By Taltirelin: Injectable Taltirelin; Oral Taltirelin
4) By Histrelin: Histrelin Implant; Histrelin Injection
5) By Other Type: Triptorelin; Buserelin; Nafarelin For further insights on this market, request a sample here

North America was the largest region in the gonadotropin-releasing hormone (GnRH) agonist market in 2024. The regions covered in the gonadotropin-releasing hormone (GnRH) agonist market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the gonadotropin-releasing hormone (GnRH) agonist market are Pfizer Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Sandoz Group AG, Ipsen Pharma, Aurobindo Pharma Limited, Cipla Limited, Dr Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Ferring Pharmaceuticals, Amneal Pharmaceuticals Inc., Endo International plc, Lupin Limited, Gland Pharma Limited, Glenmark Pharmaceuticals Ltd., Zydus Lifesciences Limited, Bachem Holding AG, Tolmar Pharmaceuticals Inc., Debiopharm Group, Sun Pharmaceutical Industries Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Advancements In Oral Androgen Deprivation Therapy For Advanced Prostate Cancer. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon